Development of a Pharmacoeconomic Model to Assess the Cost Effectiveness of Pharmacogenomics Tests in Chronic Heart Failure: The Case of Ivabradine

Autor:	Jason R. Guertin, Ange Christelle Iliza, F Fanton Aita, Jacques LeLorier, Alexis Matteau, Dominic Mitchell
Rok vydání:	2016
Předmět:	medicine.medical_specialty Cost effectiveness business.industry Health Policy Public Health Environmental and Occupational Health medicine.disease Heart failure Internal medicine Pharmacogenomics medicine Cardiology Intensive care medicine business Ivabradine medicine.drug
Zdroj:	Value in Health. 19:A48-A49
ISSN:	1098-3015
DOI:	10.1016/j.jval.2016.03.119
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f8dccc96fb05c86818984b0fb775584d https://doi.org/10.1016/j.jval.2016.03.119 Zobrazit plný text záznamu Full Text from ScienceDirect